A detailed history of Efg Capital International Corp. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Efg Capital International Corp. holds 11,711 shares of RCKT stock, worth $216,770. This represents 0.05% of its overall portfolio holdings.

Number of Shares
11,711
Holding current value
$216,770
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

BUY
$16.59 - $23.6 $194,285 - $276,379
11,711 New
11,711 $233 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.4B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Efg Capital International Corp. Portfolio

Follow Efg Capital International Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Capital International Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Capital International Corp. with notifications on news.